TY  -  
T1  - Centralized repeated resectability assessment of patients with colorectalliver metastases during first-line treatment : prospective study 
SN  -  /  
UR  - http://hdl.handle.net/10138/334924 
T3  -  
A1  - Isoniemi, H.; Uutela, A.; Nordin, A.; Lantto, E.; Kellokumpu, I.; Ovissi, A.; Kosunen, J.; Kallio, R.; Soveri, L. M.; Salminen, T.; Ålgars, A.; Lamminmaki, A.; Halonen, P.; Ristamaki, R.; Räsänen, J.; Karjula, H.; Vaalavuo, Y.; Lavonius, M.; Österlund, P. 
A2  -  
PB  -  
Y1  - 2021 
LA  - eng 
AB  - Y Background: Metastasectomy is probably underused in metastatic colorectal cancer. The aim of this study was to investigate the effect of centralized repeated assessment on resectability rate of liver metastases. Methods: The prospective RAXO study was a nationwide study in Finland. Patients with treatable metastatic colorectal cancer at any site were eligible. This planned substudy included patients with baseline liver metastases between 2012 and 2018. Resectability was reassessed by the multi... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - PORTAL-VEIN EMBOLIZATION; LIVER METASTASES; HEPATIC RESECTION; SYSTEMIC CHEMOTHERAPY; EXTRAHEPATIC DISEASE; 2-STAGE HEPATECTOMY; CANCER; SURVIVAL; BEVACIZUMAB; CETUXIMAB; 3126 Surgery, anesthesiology, intensive care, radiology 
N1  -   
PP  -  
ER  -